cjc-1295 no dac synergy with ipamorelin (No DAC) + – Pacific Edge Labs LLC CJC-1295 and Ipamorelin: Should You

References (Educational Citations) Landmark Phase II trial Randomized placebo-controlled obesity trial, 24week duration, tesofensine 0.25, 0.5, 1.0 mg daily

Prefer to talk

Continuous protein synthesis

thanks grant support from the US National Institute of Health and American Heart Association

This enhanced peptide variant delivers targeted benefits that can significantly improve quality of life and physical capabilities

Clinical Applications of Sermorelin Supporting age-related growth hormone decline Improving sleep quality and overnight recovery Maintaining lean muscle mass Supporting energy, vitality, and metabolic function Long-term anti-aging and wellness optimization Sermorelin aligns particularly well with natural hormone rhythms because GH production peaks during sleep